Loading...
Loading...
Among the 4 tracked institutional investors we monitor, DRUG (BRIGHT MINDS BIOSCIENCES INC) is held with a combined value of $57.13M across 779,567 shares. The largest holder is BlackRock, Inc. with a position worth $45.38M (0.00% of their portfolio). VANGUARD GROUP INC opened a new position in the most recent quarter. 2 funds increased their holdings. 1 fund reduced its position.
Total Institutional Value
$57.13M
Total Shares Held
779,567
Institutional Holders
4
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | BlackRock, Inc. | $45.38M | 0.00% | +57.8% |
| 2 | STATE STREET CORP | $7.90M | 0.00% | +40.1% |
| 3 | VANGUARD GROUP INC | $3.79M | 0.00% | New |
| 4 | FMR LLC | $59.78K | 0.00% | -26.3% |
As of the latest SEC 13F filings, BlackRock, Inc. is the largest institutional holder of DRUG with a position worth $45.38M, representing 0.00% of their portfolio. In total, 4 institutional investors hold DRUG with a combined value of $57.13M.
In the most recent quarter, 1 fund opened a new position in DRUG. Additionally, 2 increased their holdings and 1 reduced their positions.
Institutional investors hold $57.13M worth of DRUG stock across 4 positions. The largest institutional holder is BlackRock, Inc. with $45.38M in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For DRUG, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their DRUG positions.